However, the present results have face validity given the agreement between [18F]-THK5351 uptake and the known topology of tau distribution in PSP patients and the topology of astrogliosis in the patient groups under investigation, respectively. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.